Adverse Outcomes in Patients with Atrial Fibrillation and a Pacemaker: A Cohort Study [0.03%]
心房颤动合并起搏器患者的不良预后：一项队列研究
Vincent Meier,Stefanie Aeschbacher,Michael Coslovsky et al.
Vincent Meier et al.
Background and aims: Patients with atrial fibrillation (AF) are at a high risk of adverse cardiovascular outcomes. Little is known about the specific population of AF patients with implanted pacemaker (PM) and their progn...
QTcNet: A Deep Learning Model for Direct Heart Rate Corrected QT Interval Estimation [0.03%]
基于深度学习的直接估计心率矫正的QT间期模型
Lucas Plagwitz,Florian Doldi,Jannes Magerfleisch et al.
Lucas Plagwitz et al.
Background and aims: Automated QTc measurements from commercial ECG systems often diverge from expert readings. We developed QTcNet, a deep-learning model trained and validated on multiple large ECG datasets to improve au...
Implementation of new concise care pathways into a software tool to detect and manage comorbidities in older patients with atrial fibrillation: the Horizon 2020 EHRA-PATHS project [0.03%]
在老年房颤患者中实施新的简明诊疗路径以检测和管理合并症：欧洲心脏节律协会路径项目的地平线2020计划EHRA-PATHS项目
Rana Önder,Lien Desteghe,Eline Vandeput et al.
Rana Önder et al.
Vascular cell adhesion molecule 1: a marker for atrial fibrillation and heart failure risk [0.03%]
血管细胞粘附分子1：房颤和心力衰竭风险的标志物
Jonas Alexander Baadsgaard,Oliver Bundgaard Vad,August Krebs Hessellund et al.
Jonas Alexander Baadsgaard et al.
Background and aims: The plasma protein soluble vascular cell adhesion molecule 1 (sVCAM-1) has been suggested as a biomarker for atrial fibrillation (AF). This study aimed to evaluate sVCAM-1 as a marker of AF and heart ...
Repeat Ablation for Persistent Atrial Fibrillation - what lies beyond lines and veins? [0.03%]
持续性房颤射频消融术的再消融困境：线性消融和血管通路之外的思考
Lucas V A Boersma,Sing-Chien Yap
Lucas V A Boersma
Influence of proton pump inhibitors on the incidence and clinical course of oesophageal fistula following catheter ablation for atrial fibrillation: a subanalysis of the POTTER-AF study [0.03%]
质子泵抑制剂对房颤导管消融后食管瘘发生率和临床经过的影响：POTTER-AF研究的亚组分析
Thomas Beiert,Vincent Knappe,Andreas Zietzer et al.
Thomas Beiert et al.
Anterior Mitral Isthmus Line using Pulsed-Field Ablation with the Pentaspline catheter or Radiofrequency Ablation: procedural characteristics, safety, and mid-term outcomes [0.03%]
脉冲场消融五分线导管或射频消融左房前壁肺静脉隔离的特征、安全性及中期疗效：一项回顾性研究
Jonas Brügger,Corinne Isenegger,Fabian Jordan et al.
Jonas Brügger et al.
Background and aim: Pulsed-field ablation (PFA) is a non-thermal energy source for pulmonary vein isolation (PVI), offering advantages in safety and procedural efficiency. However, data comparing anterior mitral isthmus l...
Vascular access and closure management for electrophysiological interventions in 2025: a Clinical Consensus Statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Surgery [0.03%]
2025年心律失常导管消融的血管通路和闭合管理：欧洲心脏节律协会、欧洲心血管导管治疗协会及欧洲心脏病学会心血管外科工作组临床共识声明
Tom J R De Potter,Chiara Valeriano,Finn Akerstrom et al.
Tom J R De Potter et al.
Implantable Cardioverter Defibrillators for Long QT syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia? (Not so fast, Louis) [0.03%]
长QT综合征和儿茶酚胺多形性室速需要植入式心脏复律除颤器吗？(Louis，慢点)
Peter J Schwartz,Michael J Ackerman
Peter J Schwartz
Few medical decisions have a greater impact on the life of patients affected by either LQTS or CPVT as the one to recommend an ICD or not. If the decision is correct, a life might be saved or a litany of ICD-related complications might be a...
Association between the Baseline Health Status and Long-Term Outcomes After Catheter Ablation for Atrial Fibrillation [0.03%]
房颤射频消融术的长期疗效与基线健康状况的关系研究
Shuhei Yamashita,Seiji Takatsuki,Shuhei Yano et al.
Shuhei Yamashita et al.